Crescita Therapeutics Stock Analysis

Crescita Pink Sheet Analysis Notes

The company has price-to-book (P/B) ratio of 0.66. Some equities with similar Price to Book (P/B) outperform the market in the long run. Crescita Therapeutics has Price/Earnings (P/E) ratio of 490.0. The entity had not issued any dividends in recent years. Crescita Therapeutics Inc., a dermatology company, provides non-prescription skincare products and prescription drug products in Canada, the United States, and internationally. Crescita Therapeutics Inc. was incorporated in 2016 and is headquartered in Laval, Canada. Crescita Therapeutics is traded on OTC Exchange in the United States.The quote for Crescita Therapeutics is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. For more info on Crescita Therapeutics please contact the company at 905 673 4297 or go to https://www.crescitatherapeutics.com.

Crescita Therapeutics Investment Alerts

Crescita Market Capitalization

The company currently falls under 'Micro-Cap' category with a current market capitalization of 11.42 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Crescita Therapeutics's market, we take the total number of its shares issued and multiply it by Crescita Therapeutics's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Crescita Profitablity

The company has Profit Margin (PM) of 0.03 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.04 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.04.

Technical Drivers

As of the 3rd of March, Crescita Therapeutics shows the risk adjusted performance of (0.09), and Mean Deviation of 0.3979. Crescita Therapeutics technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Please confirm Crescita Therapeutics market risk adjusted performance and total risk alpha to decide if Crescita Therapeutics is priced correctly, providing market reflects its regular price of 0.39 per share. As Crescita Therapeutics appears to be a penny stock we also recommend to validate its information ratio numbers.

Crescita Therapeutics Price Movement Analysis

Crescita Therapeutics Predictive Daily Indicators

Crescita Therapeutics Forecast Models

Crescita Therapeutics' time-series forecasting models are one of many Crescita Therapeutics' pink sheet analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Crescita Therapeutics' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Pink Sheet analysis is the technique used by a trader or investor to examine and evaluate how Crescita Therapeutics prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Crescita shares will generate the highest return on investment. We also built our pink sheet analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Pink Sheet such as Crescita Therapeutics. By using and applying Crescita Pink Sheet analysis, traders can create a robust methodology for identifying Crescita entry and exit points for their positions.

When running Crescita Therapeutics' price analysis, check to measure Crescita Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Crescita Therapeutics is operating at the current time. Most of Crescita Therapeutics' value examination focuses on studying past and present price action to predict the probability of Crescita Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Crescita Therapeutics' price. Additionally, you may evaluate how the addition of Crescita Therapeutics to your portfolios can decrease your overall portfolio volatility.